Rhabdomyosarcoma, Peritonsillar Abscess, Round Blue Cell Tumour, Pediatric Malignancy Bansal, E. , Singhal, P. , Jhajhadia, B ...

The TP63 gene, an important member of the TP53 family, contains two independent promoters that drive the transcription of TAp63 and ΔNp63, respectively. Through alternative splicing, TAp63 and ΔNp63 ...

Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype is strongly associated with Epstein-Barr virus (EBV) infection, whereas emerging data suggest that a subset ...

Please provide your email address to receive an email when new articles are posted on . Patients with nasopharyngeal cancer who received morning radiotherapy survived longer than those treated later ...

Reston, VA (June 10, 2025)—A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly ...

In a phase 3 trial, toripalimab-based chemotherapy with radiotherapy without concurrent cisplatin achieved noninferior 3-year failure-free survival compared with standard therapy in patients with ...

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in patients with HPV-positive oropharyngeal cancer (ReACT 1.0). REMATCH2201: A phase II study on reducing surgical ...

NPC is a disease that develops in a concealed area behind the nose and frequently presents with non-specific early signs, and in Malaysia, it is one of the most common cancers affecting men, with ...

Throat cancer remains one of the most challenging yet increasingly treatable forms of cancer affecting thousands of Americans each year. This complex disease impacts the pharynx (throat) or larynx ...